04Mar
Global Private Equity Newsletter - Winter 2020 Edition: Deals in the Life Sciences Sector Article 1: Value Drivers and Risks
As the private equity industry matures, and the deal landscape becomes more competitive, private equity sponsors are becoming more prepared and capable of investing in sectors previously considered overly-regulated, requiring advanced chemistry or...
By:
Dechert LLP
Related
In Western Standard, LLC, v. SourceHOV Holdings, Inc. and Pangea Acquisitions, Inc., C.A. No. 2018-0...
Read More >
Last September, Makan Delrahim, the Assistant Attorney General for the Antitrust Division of the Dep...
Read More >
Recently, the North Carolina Supreme Court issued a decision impacting the application of the econom...
Read More >
Seyfarth Synopsis: The NLRB recently published a Notice of Proposed Rule Making regarding three prop...
Read More >
While the impact of the COVID-19 pandemic on the real estate development industry remains unclear, s...
Read More >
The recent amendment to HIV Law number 7771, includes amendments to some articles of the Labor Code....
Read More >